[A novel mutation of KCNQ2 gene in a Chinese family with benign familial neonatal convulsions].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi

Department of Neurology, Xiangya Hospital, Central South University, Changsha Hunan, 410008 PR China.

Published: December 2003

Objective: To diagnose a Chinese benign familial neonatal convulsions (BFNC) family at the level of gene and investigate its molecular pathogenesis.

Methods: All family members were studied by clinical examinations and linkage analysis. Mutation analysis of KCNQ2 gene was made by means of polymerase chain reaction (PCR)-direct sequencing and PCR-single strand conformation polymorphism (SSCP) in the proband, 16 family members and 72 unrelated normal individuals.

Results: Linkage analysis hinted the linkage of BFNC to KCNQ2, while the linkage to KCNQ3 was excluded. Mutation 1931delG of KCNQ2 gene was found in the proband by DNA-direct sequencing. The same SSCP variant as the proband's was showed in the rest affected members of this family but not in the unaffected members of this family and all of the 72 unrelated normal individuals.

Conclusion: 1931delG of KCNQ2 gene can cause BFNC in China and is novel mutation. The combination of linkage analysis and gene analysis is useful for gene diagnosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

kcnq2 gene
16
linkage analysis
12
novel mutation
8
benign familial
8
familial neonatal
8
family members
8
unrelated normal
8
1931delg kcnq2
8
members family
8
analysis gene
8

Similar Publications

Article Synopsis
  • The study focuses on Juvenile Myoclonic Epilepsy (JME), a common genetic epilepsy in adolescents and adults, aiming to identify rare genetic variants linked to the condition.
  • Researchers used Whole Exome Sequencing to analyze ten JME patients and confirmed their findings with Sanger DNA sequencing, identifying eight variants across multiple genes.
  • The identified genetic variants are believed to play crucial roles in neuronal functions, suggesting they may contribute to the development of JME by affecting seizure mechanisms.
View Article and Find Full Text PDF

Background: We aimed to estimate real-world evidence of the prevalence rate of genetic developmental and epileptic encephalopathies (DEEs) in the Italian population over a 11-year period.

Methods: Fifteen paediatric and adult tertiary Italian epilepsy centres participated in a survey related to 98 genes included in the molecular diagnostic workflows of most centres. We included patients with a clinical diagnosis of DEE, caused by a pathogenic or likely pathogenic variant in one of the selected genes, with a molecular diagnosis established between 2012 and 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * Whole exome sequencing and other analyses revealed important genetic variants: bi-allelic variants in MOCS1 linked to molybdenum cofactor deficiency, and a KCNQ2 variant associated with seizures.
  • * The research demonstrated that whole exome sequencing can effectively diagnose the genetic causes of neonatal seizures, contributing to our understanding of related phenotypes, especially with sodium channel gene duplications.
View Article and Find Full Text PDF

Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies.

Cells

October 2024

Institut de Recherches Servier, Rue Francis Perrin, 91190 Gif-sur-Yvette, France.

Developmental and Epileptic Encephalopathies (DEEs) represent a clinically and genetically heterogeneous group of rare and severe epilepsies. DEEs commonly begin early in infancy with frequent seizures of various types associated with intellectual disability and leading to a neurodevelopmental delay or regression. Disease-causing genomic variants have been identified in numerous genes and are implicated in over 100 types of DEEs.

View Article and Find Full Text PDF

Objective: To evaluate the etiology-specific diagnosis of early-onset developmental epileptic encephalopathies (EO-DEEs) in a nationwide Turkish cohort to determine the implications for therapeutic management.

Methods: The cohort comprised 1450 patients who underwent EO-DEE. The utility of genetic testing was assessed with respect to the initial phases of next generation sequencing (NGS) (2005-2013) and the current NGS era (2014-2022).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!